Concepedia

Therapeutic Interchange Analysis

Therapeutic Interchange Analysis is a pharmacy analytics method that identifies and evaluates opportunities for substituting clinically equivalent medications within the same therapeutic class to optimize therapeutic outcomes, reduce costs, and maintain safety and efficacy standards.

21

Publications

501

Citations

59

Authors

38

Institutions

Publications per year

2017–2026

1

Parents

Publications

21

Pharmacological and clinical differences between low-molecular-weight heparins: implications for prescribing practice and therapeutic interchange.

Geno J. Merli, J. B. Groce · PubMed · 2010 · 110 citations

, , +17

Prevalence and cost savings of therapeutic interchange among U.S. hospitals

Jill M. Schachtner, Roy Guharoy, Joseph J. Medicis et al. · American Journal of Health-System Pharmacy · 2002 · 49 citations · Full text

, , +13

Changing relationship between pharmacists and physicians

David L. Cowen · American Journal of Health-System Pharmacy · 1992 · 36 citations

, , +13

Association between formulary strategies and hospital drug expenditures

Thomas K. Hazlet, Teh-wei Hu · American Journal of Health-System Pharmacy · 1992 · 33 citations

, , +16

Applying Scientific Criteria to Therapeutic Interchange: A Balanced Analysis of Low-Molecular-Weight Heparins

Geno J. Merli, Gordon J. Vanscoy, Thomas L. Rihn et al. · Journal of Thrombosis and Thrombolysis · 2001 · 33 citations

, , +6

1–5 of 21

Authors

59

  1. NV
    Norman V. Carroll

    Virginia Commonwealth University, United States

    3 publications · 63 citations

    3

    h-index

  2. GJ
    Geno J. Merli

    Thomas Jefferson University Hospital, United States

    2 publications · 143 citations

    2

    h-index

  3. JB
    J. B. Groce

    Moses H Cone Memorial Hospital, United States

    2 publications · 143 citations

    2

    h-index

  4. DC
    Desong Chen

    National University of Singapore, Singapore

    1 publications · 12 citations

    1

    h-index

  5. BA
    Bhakti Arondekar

    GlaxoSmithKline (United States), United States

    1 publications · 14 citations

    1

    h-index

1–5 of 59

Institutions

38

  1. University of California, San Francisco

    San Francisco, United States

    2 h-index

    2 publications

    45 citations

  2. Virginia Commonwealth University Medical Center

    Richmond, United States

    2 h-index

    2 publications

    36 citations

  3. University of Pittsburgh

    Pittsburgh, United States

    2 h-index

    4 publications

    105 citations

  4. Dermatrials Research

    Hamilton, Canada

    1 h-index

    1 publications

    20 citations

  5. Duquesne University

    Pittsburgh, United States

    1 h-index

    1 publications

    33 citations

  6. Indiana University – Purdue University Indianapolis

    Indianapolis, United States

    1 h-index

    1 publications

    12 citations

  7. UPMC Altoona

    Altoona, United States

    1 h-index

    1 publications

    49 citations

  8. University of Michigan

    Ann Arbor, United States

    1 h-index

    1 publications

    10 citations

1–8 of 38

Venues

  1. American Journal of Health-System Pharmacy

    AJHP · 9 publications · 204 citations

    9

    h-index

  2. PubMed

    Repository · 6 publications · 195 citations

    6

    h-index

  3. Annals of Pharmacotherapy

    1 publications · 24 citations

    1

    h-index

  4. Journal of Human Hypertension

    1 publications · 12 citations

    1

    h-index

  5. PLoS ONE

    1 publications · 12 citations

    1

    h-index

1–5